Antibody against the CSF-1R

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9982055
APP PUB NO 20170002081A1
SERIAL NO

15214220

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRANSGENE S AILLKIRCH GRAFFENSTADEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Geist, Michel Brumath, FR 9 203
Grellier, Benoit Strasbourg, FR 3 24
Haegel, Hélène Strasbourg, FR 7 143
Marchand, Jean-Baptiste Obernai, FR 17 136
Thioudellet, Christine Strasbourg, FR 8 188

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 29, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 29, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00